ThermoGenesis used technology protected by two patents, titled Blood Components Separator Disk, Harvest claimed in court papers filed yesterday in U.S. District Court in Wilmington, Delaware.
“ThermoGenesis’s actions have, at a minimum, shown willful blindness or indifference” to the patents, Harvest said in its complaint.
Both companies provide technologies used to help separate blood and bone marrow into components, a key part of the process for therapies related to stem cells.
Harvest, based in Plymouth, Massachusetts, is a unit of Tokyo-based Terumo Corp. (4543), a medical-device maker.
In October 2008 a distributor, who was not sued as part of the patent case, gave ThermoGenesis confidential information about Harvest’s technology, Harvest claimed in the complaint.
Officials at ThermoGenesis did not immediately return a call left at the company’s headquarters in Rancho Cordova, California.
The case is Harvest Technologies Corp. v. ThermoGenesis Corp., 12-cv-01354, U.S. District Court, District of Delaware (Wilmington).
To contact the reporter on this story: Steven Church in Wilmington, Delaware, at email@example.com.